ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

APZ Aptilon Corporation

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Aptilon Corporation TSXV:APZ TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Aptilon Announces $1,000,000 Loan from FIER CPVC-Montreal

17/08/2010 11:25pm

PR Newswire (Canada)


Aptilon Corporation (TSXV:APZ)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Aptilon Corporation Charts.
MONTREAL, Aug. 17 /CNW/ -- MONTREAL, Aug. 17 /CNW Telbec/ - Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), an innovative leader of on-line marketing services to physicians, today announced that it has obtained a $1,000,000 loan (the "Loan") from FIER CPVC-Montreal LP (the "FIER"). The Loan bears interest at an annual rate of 12% and is due on demand. The Loan is secured by a lien on Aptilon's accounts receivable, inventory and certain short-term assets. Aptilon Holdings Inc., a wholly-owned subsidiary of Aptilon, has guaranteed the loan and also granted the FIER a lien over its accounts receivable. The Loan replaces the $500,000 loan previously granted by the FIER and announced in a press release dated January 8, 2010. About Aptilon Corporation ------------------------- Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with physicians via the Internet through its innovative AxcelRx(SM) Live video detailing platform which hosts promotional, peer selling and other sales and marketing programs. Top ten US pharmaceutical companies have adopted Aptilon's AxcelRx(SM) solution to reach physicians. Aptilon provides the infrastructure necessary for pharmaceutical companies to build physician awareness, understanding, and product preference during all stages of a product's life cycle, from pre-launch education through end stage support. For more information, visit www.aptilon.com. AxcelRx(SM) and ReachNet(SM) are service marks of Aptilon Corporation. Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Denis Martineau, President, Aptilon Corporation, 1-888-544-8866, investors@aptilon.com

Copyright

1 Year Aptilon Corporation Chart

1 Year Aptilon Corporation Chart

1 Month Aptilon Corporation Chart

1 Month Aptilon Corporation Chart